Baidu
map

2020 SMFM咨询系列#51:剖腹产术中血栓栓塞的预防

2020-08-22 母胎医学会 Am J Obstet Gynecol . 2020 Aug;223(2):B11-B17.

2020年8月,母胎医学会(SMFM)发布了剖腹产术中血栓栓塞的预防指导。静脉血栓栓塞时导致孕产妇发病和死亡的主要原因,产后尤其剖宫产后静脉的风险血栓栓塞风险升高,本文主要针对剖腹产术中血栓栓塞的预防

中文标题:

2020 SMFM咨询系列#51:剖腹产术中血栓栓塞的预防

英文标题:

Society for Maternal-Fetal Medicine Consult Series #51: Thromboembolism prophylaxis for cesarean delivery

发布机构:

母胎医学会

发布日期:

2020-08-22

简要介绍:

2020年8月,母胎医学会(SMFM)发布了剖腹产术中血栓栓塞的预防指导。静脉血栓栓塞时导致孕产妇发病和死亡的主要原因,产后尤其剖宫产后静脉的风险血栓栓塞风险升高,本文主要针对剖腹产术中血栓栓塞的预防提供指导建议。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2020 SMFM咨询系列#51:剖腹产术中血栓栓塞的预防.pdf)] GetToolGuiderByIdResponse(projectId=1, id=b25051c0019e39e9, title=2020 SMFM咨询系列#51:剖腹产术中血栓栓塞的预防, enTitle=Society for Maternal-Fetal Medicine Consult Series #51: Thromboembolism prophylaxis for cesarean delivery, guiderFrom=Am J Obstet Gynecol . 2020 Aug;223(2):B11-B17., authorId=0, author=, summary=2020年8月,母胎医学会(SMFM)发布了剖腹产术中血栓栓塞的预防指导。静脉血栓栓塞时导致孕产妇发病和死亡的主要原因,产后尤其剖宫产后静脉的风险血栓栓塞风险升高,本文主要针对剖腹产术中血栓栓塞的预防, cover=https://img.medsci.cn/2020920/1600615592695_2020535.jpg, journalId=0, articlesId=null, associationId=951, associationName=母胎医学会, associationIntro=null, copyright=0, guiderPublishedTime=Sat Aug 22 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年8月,母胎医学会(SMFM)发布了剖腹产术中血栓栓塞的预防指导。静脉血栓栓塞时导致孕产妇发病和死亡的主要原因,产后尤其剖宫产后静脉的风险血栓栓塞风险升高,本文主要针对剖腹产术中血栓栓塞的预防提供指导建议。</p> </div> </div> </div>, tagList=[TagDto(tagId=991, tagName=血栓栓塞), TagDto(tagId=1754, tagName=剖腹产)], categoryList=[CategoryDto(categoryId=29, categoryName=麻醉疼痛科, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1754, guiderKeyword=剖腹产, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3096, appHits=143, showAppHits=0, pcHits=532, showPcHits=2953, likes=0, shares=6, comments=9, approvalStatus=1, publishedTime=Sun Sep 20 23:45:29 CST 2020, publishedTimeString=2020-08-22, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Sep 20 23:26:36 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 19:16:17 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 SMFM咨询系列#51:剖腹产术中血栓栓塞的预防.pdf)])
2020 SMFM咨询系列#51:剖腹产术中血栓栓塞的预防.pdf
下载请点击:
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=967012, encodeId=99f096e01267, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e5a3197000, createdName=makedemahua, createdTime=Wed May 19 19:45:55 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960668, encodeId=518c96066839, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58d25483500, createdName=ms9000001532925281, createdTime=Mon Apr 26 16:00:56 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960659, encodeId=598c960659c4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58d25483500, createdName=ms9000001532925281, createdTime=Mon Apr 26 15:23:42 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948591, encodeId=cf109485916d, content=谁有中文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200813/275713393b244fa699928e0384941054/2d82f6f558f0411a9f4e161d898d2d8c.jpg, createdBy=72c15410740, createdName=妮子, createdTime=Tue Mar 16 10:09:29 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910653, encodeId=63a0910653b2, content=想看看~~~~, beContent=null, objectType=guider, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c3c1692607, createdName=心愿依在, createdTime=Thu Dec 24 16:38:09 CST 2020, time=2020-12-24, status=1, ipAttribution=)]
    2021-05-19 makedemahua

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=967012, encodeId=99f096e01267, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e5a3197000, createdName=makedemahua, createdTime=Wed May 19 19:45:55 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960668, encodeId=518c96066839, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58d25483500, createdName=ms9000001532925281, createdTime=Mon Apr 26 16:00:56 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960659, encodeId=598c960659c4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58d25483500, createdName=ms9000001532925281, createdTime=Mon Apr 26 15:23:42 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948591, encodeId=cf109485916d, content=谁有中文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200813/275713393b244fa699928e0384941054/2d82f6f558f0411a9f4e161d898d2d8c.jpg, createdBy=72c15410740, createdName=妮子, createdTime=Tue Mar 16 10:09:29 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910653, encodeId=63a0910653b2, content=想看看~~~~, beContent=null, objectType=guider, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c3c1692607, createdName=心愿依在, createdTime=Thu Dec 24 16:38:09 CST 2020, time=2020-12-24, status=1, ipAttribution=)]
    2021-04-26 ms9000001532925281

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=967012, encodeId=99f096e01267, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e5a3197000, createdName=makedemahua, createdTime=Wed May 19 19:45:55 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960668, encodeId=518c96066839, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58d25483500, createdName=ms9000001532925281, createdTime=Mon Apr 26 16:00:56 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960659, encodeId=598c960659c4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58d25483500, createdName=ms9000001532925281, createdTime=Mon Apr 26 15:23:42 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948591, encodeId=cf109485916d, content=谁有中文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200813/275713393b244fa699928e0384941054/2d82f6f558f0411a9f4e161d898d2d8c.jpg, createdBy=72c15410740, createdName=妮子, createdTime=Tue Mar 16 10:09:29 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910653, encodeId=63a0910653b2, content=想看看~~~~, beContent=null, objectType=guider, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c3c1692607, createdName=心愿依在, createdTime=Thu Dec 24 16:38:09 CST 2020, time=2020-12-24, status=1, ipAttribution=)]
    2021-04-26 ms9000001532925281

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=967012, encodeId=99f096e01267, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e5a3197000, createdName=makedemahua, createdTime=Wed May 19 19:45:55 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960668, encodeId=518c96066839, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58d25483500, createdName=ms9000001532925281, createdTime=Mon Apr 26 16:00:56 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960659, encodeId=598c960659c4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58d25483500, createdName=ms9000001532925281, createdTime=Mon Apr 26 15:23:42 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948591, encodeId=cf109485916d, content=谁有中文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200813/275713393b244fa699928e0384941054/2d82f6f558f0411a9f4e161d898d2d8c.jpg, createdBy=72c15410740, createdName=妮子, createdTime=Tue Mar 16 10:09:29 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910653, encodeId=63a0910653b2, content=想看看~~~~, beContent=null, objectType=guider, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c3c1692607, createdName=心愿依在, createdTime=Thu Dec 24 16:38:09 CST 2020, time=2020-12-24, status=1, ipAttribution=)]
    2021-03-16 妮子

    谁有中文版

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=967012, encodeId=99f096e01267, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e5a3197000, createdName=makedemahua, createdTime=Wed May 19 19:45:55 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960668, encodeId=518c96066839, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58d25483500, createdName=ms9000001532925281, createdTime=Mon Apr 26 16:00:56 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960659, encodeId=598c960659c4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58d25483500, createdName=ms9000001532925281, createdTime=Mon Apr 26 15:23:42 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948591, encodeId=cf109485916d, content=谁有中文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200813/275713393b244fa699928e0384941054/2d82f6f558f0411a9f4e161d898d2d8c.jpg, createdBy=72c15410740, createdName=妮子, createdTime=Tue Mar 16 10:09:29 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910653, encodeId=63a0910653b2, content=想看看~~~~, beContent=null, objectType=guider, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c3c1692607, createdName=心愿依在, createdTime=Thu Dec 24 16:38:09 CST 2020, time=2020-12-24, status=1, ipAttribution=)]
    2020-12-24 心愿依在

    想看看~~~~

    0

拓展阅读

2019 国际共识声明:剖腹产期间宫缩剂的应用

国外麻醉相关专家组(统称) · 2019-07-15

SMFM 特别声明:剖腹产手术安全检查表

母胎医学会(SMFM,Society for Maternal-Fetal Medicine) · 2021-07-26

2021 NICE指南:剖腹产(NG.192)

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2021-03-31

2021 WHO 世卫组织关于剖腹产妇女预防性抗生素的建议

世界卫生组织(WHO,The World Health Organization) · 2021-06-18

2023 NICE 指南:剖腹产[NG192]

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2023-06-21

2023 NICE 指南更新:剖腹产[NG192]

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2023-08-23

Baidu
map
Baidu
map
Baidu
map